Vivian W. Doelling, Ph.D.
Vice President, Emerging Company DevelopmentDepartment: Emerging Company Development
Vivian Doelling joined NCBiotech in February of 2015 as Director, Business and Technology Development. In this role, she supports the start-up and growth of life science companies in North Carolina primarily through management of the Center’s loan programs. Additionally, Vivian identifies and mentors early stage and loan portfolio companies as well as supporting key scientific/investor events.
Vivian has strong experience in life science product R&D leadership, including senior roles at Embrex/Pfizer, ILS, and SCYNEXIS. Her background includes starting and managing research, development and commercial operations for human and animal health products. Vivian has broad expertise in technology assessment and strategically managed a wide range of collaborative research and licensing agreements with universities, large pharmaceutical partners and customers.
Vivian currently serves on the Industry Advisory Board for the Masters of Microbial Biotechnology (MMB) program at North Carolina State University and is an Executive Council member of the North Carolina One Health Collaborative.
Dr. Doelling holds an undergraduate degree from Dickinson College in Biology and a Ph.D. from Purdue University in Biochemistry.